Sanofi-aventis has won FDA approval for Apidra SoloSTAR, a prefilled disposable pen, for children with type 1 diabetes and adults with type 1 or 2 diabetes. Apidra, which has been on the market ...

Insulin Glulisine of rDNA Origin (Apidra) for Diabetes Insulin glulisine (Apidra, made by Aventis) was approved by the FDA this week for the treatment of adult patients with diabetes mellitus and ...

In the ELEONOR study, the addition of one APIDRA(R) injection resulted in a further A1C drop of 0.7-0.8%. In the OPAL study, A1C scores improved, significantly dropping 0.4% from baseline to ...

Insulin Glulisine [rDNA origin] Injection (Apidra) Updated for Use in Pediatric Patients On October 24, 2008, the FDA approved safety labeling revisions for insulin glulisine [rDNA origin ...

WASHINGTON The Food and Drug Administration approved Sanofi-Aventis drug Apidra on Friday, FDA records show. The injectable drug, known generically as insulin glulusine (rDNA origin), is approved ...